Oct 9, 2026 08:01AM
Oct 9, 2026 08:00AM
Dec 15, 2025 08:01AM
Dec 15, 2025 08:00AM
Nov 12, 2025 04:05PM
Oct 3, 2025 04:10AM
Sep 26, 2025 04:23AM Citizens JMP Reiterates Market Outperform Rating on Quince Therapeutics Inc. (QNCX)
Sep 11, 2025 04:05PM
Aug 12, 2025 04:18AM
Aug 11, 2025 04:05PM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jun 25, 2025 04:05PM
Jun 18, 2025 04:05PM Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities
Jun 12, 2025 05:15PM
Jun 12, 2025 05:15PM
Jun 3, 2025 04:05PM
May 13, 2025 08:00AM
Mar 24, 2025 04:05PM
Feb 7, 2025 08:00AM
Feb 4, 2025 04:06PM Quince Therapeutics (QNCX) Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
Feb 4, 2025 04:05PM
Jan 27, 2025 08:00AM
Nov 13, 2024 04:05PM
Nov 12, 2024 04:05PM
Nov 12, 2024 04:05PM
Nov 11, 2024 04:05PM
Nov 11, 2024 04:05PM Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting
Aug 15, 2024 07:01AM
Aug 15, 2024 07:00AM
Aug 13, 2024 04:05PM
Jun 25, 2024 07:00AM
Jun 3, 2024 07:00AM
Jun 3, 2024 07:00AM
May 13, 2024 07:00AM Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Apr 1, 2024 07:00AM
Feb 15, 2024 07:03AM
Feb 15, 2024 07:00AM
Oct 23, 2023 07:00AM
Sep 28, 2023 04:05PM
Sep 28, 2023 04:05PM
Jul 24, 2023 07:04AM Quince Therapeutics (QNCX) to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia
Jul 24, 2023 07:00AM
Jan 30, 2023 04:05PM
Sep 16, 2022 08:03AM
Sep 16, 2022 08:00AM
Aug 1, 2022 08:13AM
Aug 1, 2022 08:00AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All